5(6)-Carboxyfluorescein diacetate as an indicator of Caenorhabditis elegans viability for the development of an in vitro anthelmintic drug assay

Talanta

Volumn 71, Issue 5, 2007, Pages 1886-1892

  Gnoula, Charlemagne ^a   Guissou, Innocent ^b   Dubois, Jacques ^a   Duez, Pierre ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

Author keywords

Anthelmintic assay; C. elegans; Pharmacological validation

Indexed keywords

ASSAYS; BIODIVERSITY; DATA REDUCTION; FLUORESCENCE MICROSCOPY; TOXIC MATERIALS; TOXICITY;

IN VITRO ANTHELMINTIC DRUG ASSAY; PHARMACOLOGICAL VALIDATION;

DYES;

EID: 33847768357     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2006.08.025     Document Type: Article

References (28)

1. OMS, Liens entre l'eau, l'assainissement, l'hygiène et la santé: faits et chiffres, OMS, Genève; 2004, 11 pp.
2. Waller P.J. Vet. Parasitol. 72 (1997) 391
3. Van Wyk J.A., and Van Schalkwyk P.C. Vet. Parasitol. 35 (1990) 61
4. Maciel S., Gimenez A.M., Gaona C., Waller P.J., and Hansen J.W. Vet. Parasitol. 62 (1996) 207
5. Simpkin K.G., and Coles G.C. J. Chem. Technol. Biotechnol. 31 (1981) 66
6. Burglin T.R., Lobos E., and Blaxter M.L. Int. J. Parasitol. 28 (1998) 395
7. Rapson E.B., Jenkins D.C., and Topley P. Res. Vet. Sci. 39 (1985) 90
8. Ho N.F.H., Sims S.M., Vidmar T.J., Day J.S., Barsuhn C.L., Thomas E.M., Geary T.G., and Thompson D.P. J. Pharm. Sci. 83 (1994) 1053
9. O'Grady J., and Kotze A.C. Exp. Parasitol. 106 (2004) 164
10. Richards J.C., Behnke J.M., and Duce I.R. Int. J. Parasitol. 25 (1995) 1185
11. I.A. Hope, C. Elegans, A Practical Approach, In: Press OU, editor New York, 1999.
12. NCCLS. Evaluation Protocols SC1-B (1992), National Committee for Clinical Laboratory Standards, Villanova, PA
13. Fonseca-Salamanca F., Martinez-Grueiro M.M., and Martinez-Fernandez A.R. Parasitol. Res. 91 (2003) 321
14. Hoefel D., Grooby W.L., Monis P.T., Andrews S., and Saint C.P. J. Microbiol. Methods 52 (2003) 379
15. Lincke C.R., The I., van Groenigen M., and Borst P. J. Mol. Biol. 228 (1992) 701
16. Usui T., Yoshida M., Honda A., Beppu T., and Horinouchi S. Gene 161 (1995) 93
17. Fardel O., Lecureur V., and Guillouzo A. Gen. Pharmacol. Vasc. Syst. 27 (1996) 1283
18. Germann U.A. Eur. J. Cancer 32 (1996) 927
19. Dean M., Hamon Y., and Chimini G. J. Lipid Res. 42 (2001) 1007
20. Kerboeuf D., Blackhall W., Kaminsky R., and von Samson-Himmelstjerna G. Int. J. Antimicrob. Agents 22 (2003) 332
21. Coles G.C., East J.M., and Jenkins S.N. Gen. Pharmacol. Vasc. Syst. 6 (1975) 309
22. Lacey E. Int. J. Parasitol. 18 (1988) 885
23. McKellar Q.A., and Jackson F. Trends Parasitol. 20 (2004) 456
24. Robertson S.J., and Martin R.J. Br. J. Pharmacol. 108 (1993) 170
25. Del Castillo J., De Mello W.C., and Morales T. Experientia 20 (1964) 141
26. Athanasiadou S.K., Jackson I., and Brandt K. Vet. Rec. 146 (2000) 728
27. Patel T.R., and McFadden B.A. Exp. Parasitol. 44 (1978) 262
28. Brenner S. Genetics 77 (1974) 71